Dogwood Therapeutics
Price & Volume
Stats
See more52W Range | $1.62-$21.78 |
Market Cap | $9.8M |
Shares Short | 37,864 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$19.25 |
News
See moreYahoo Finance • 21 days ago
Dogwood Therapeutics to Participate in Fireside Chat at the H.C. Wainwright 27th Annual Global Investment Conference
Yahoo Finance • last month
Dogwood Therapeutics Reports Second Quarter 2025 Financial Results
Yahoo Finance • 2 months ago
Dogwood Therapeutics to Report Second Quarter 2025 Financial Results on Wednesday, August 13, 2025
Yahoo Finance • 3 months ago
Dogwood Therapeutics shareholders approve equity plan amendment and elect directors
About
CEO | Mr. Gregory Duncan |
Address | 44 Milton Avenue, Alpharetta, GA, United States, 30009 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 12 |
